甲状腺上腺激素的变化跨越了雷宁独立的阿尔多斯特主义的谱
Angeline Ooi1, Hakim Khan2, Muhammad Akram3
1Monash University, Clayton, Victoria, Australia.
The Journal of clinical endocrinology and metabolism
|March 7, 2025
概括
原发性阿尔多斯特隆症 (PA) 与较高的副甲状腺激素 (PTH) 水平和尿路分泌量的增加有关. 在患有高PTH和正常的患者中考虑PA.
科学领域:
- 内分泌学 在内分泌学.
- 高血压研究 高血压研究
- 矿物质的新陈代谢.
背景情况:
- 原发性阿尔多斯顿主义 (PA) 是内分泌高血压的主要原因.
- 副甲状腺激素 (PTH) 的升高与PA有关,但这种联系在素独立的代质症中尚不清楚.
- 了解这种关系对于诊断和管理高血压至关重要.
研究的目的:
- 为了研究PTH水平与阿尔多激素过量之间的关联.
- 为了澄清PTH在氨酸独立固醇学全谱中的作用.
- 为了确定PA的潜在诊断标志物.
主要方法:
- 对462名成年患者进行回顾性分析,用PTH测量查PA.
- 根据荷尔蒙测定和测试,分类为PA",低没有PA"和非PA组.
- 评估血清PTH度和24小时尿路分泌量.
主要成果:
- 与其他组相比,患有PA的患者表现出更高的PTH水平 (中位数为5.7vs5.3vs5.1 pmol/L).
- 24小时尿路分泌量随着氨酸抑制 (4.1至4.9毫摩尔/天) 逐渐增加.
- 在PA患者中,PTH升高的可能性更高,血清度正常 (38%vs28%).
结论:
- PTH度和尿路分泌量在素独立代谢的全谱中都会上升.
- 在PTH升高和血清水平正常的个体中应考虑PA.
- 进一步的研究可能会改进PA的诊断标准.
更多相关视频
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
468
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
468
The Parathyroid Glands
1.8K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
1.8K
Hormones and Bone Tissue
2.5K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.5K
Antihypertensive Drugs: Potassium-Sparing Diuretics
429
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
429
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360


